Market Closed -
Other stock markets
|
Pre-market 11:30:12 am | |||
11 EUR | +0.92% | 10.98 | -0.18% |
2023 | VIB Vermögen AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Price slide at Dic Asset continues after profit warning | DP |
Sales 2021 | 103M 111M 9.23B | Sales 2022 | 128M 138M 11.48B | Capitalization | 563M 603M 50.33B |
---|---|---|---|---|---|
Net income 2021 | 149M 160M 13.33B | Net income 2022 | 53M 56.85M 4.74B | EV / Sales 2021 | 18.8 x |
Net Debt 2021 | 680M 730M 60.88B | Net Debt 2022 | 671M 720M 60.02B | EV / Sales 2022 | 9.61 x |
P/E ratio 2021 |
8.43
x | P/E ratio 2022 |
10.7
x | Employees | 35 |
Yield 2021 |
1.87% | Yield 2022 |
-
| Free-Float | 31.86% |
1 day | -0.18% | ||
1 week | +0.36% | ||
Current month | -1.79% | ||
1 month | -1.79% | ||
3 months | -23.82% | ||
6 months | -2.48% | ||
Current year | -20.86% |
Managers | Title | Age | Since |
---|---|---|---|
Dirk Oehme
CEO | Chief Executive Officer | 49 | 22/22/22 |
Peter Njuguna
CTO | Chief Tech/Sci/R&D Officer | 51 | 01/14/01 |
Henry Karanja
CMP | Compliance Officer | 48 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 06/23/06 | |
Jürgen Wittmann
BRD | Director/Board Member | 61 | 01/07/01 |
Gerhard Schmidt
CHM | Chairman | 67 | 13/22/13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 17 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 11 | +0.92% | 4,647 |
25/24/25 | 10.9 | +0.18% | 4,488 |
24/24/24 | 10.88 | -0.91% | 10,255 |
23/24/23 | 10.98 | -0.18% | 4,774 |
22/24/22 | 11 | +0.36% | 14,763 |
Delayed Quote Xetra, April 26, 2024 at 09:06 pm IST
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.86% | 388M | |
+36.16% | 27.94B | |
-13.14% | 26.97B | |
+21.73% | 26.95B | |
+3.57% | 25.32B | |
+44.49% | 22.58B | |
+3.66% | 19.59B | |
+6.69% | 19.52B | |
+28.54% | 16.23B | |
-14.03% | 14.98B |
- Stock Market
- Equities
- VIH1 Stock